SCHEMBL25017972

SCHEMBL25017972

CC(C)(C)OC(=O)NC1CCC(OC(=O)c2cc3ccc(/C(N)=N\O)cc3n2Cc2cccc3ccccc23)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 5/20 0.35
▸ EPHX1 P07099 1/20 0.35
▸ CACNB4 O00305 1/20 0.34
▸ CACNA1A O00555 1/20 0.34
▸ CACNA1G O43497 1/20 0.34
▸ CACNG3 O60359 1/20 0.34
▸ CACNA1F O60840 1/20 0.34
▸ CACNA1H O95180 1/20 0.34
▸ CACNB3 P54284 1/20 0.34
▸ CACNA2D1 P54289 1/20 0.34
▸ CACNG7 P62955 1/20 0.34
▸ CACNA1B Q00975 1/20 0.34
▸ CACNA1D Q01668 1/20 0.34
▸ CACNB1 Q02641 1/20 0.34
▸ CACNG1 Q06432 1/20 0.34
▸ CACNB2 Q08289 1/20 0.34
▸ CACNA1S Q13698 1/20 0.34
▸ CACNA1C Q13936 1/20 0.34
▸ CACNA1E Q15878 1/20 0.34
▸ CACNA2D4 Q7Z3S7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30180863 0.88 EPHX1 (0.36) F10EPHX1CACNB4CACNA1ACACNA1G
SCHEMBL28575247 0.86 F10 (0.39) F10L3MBTL1F2PRSS1PLA2G1B
SCHEMBL25017973 0.86 F10 (0.39) F10L3MBTL1F2PRSS1PLA2G1B
SCHEMBL21822134 0.85 DRD2 (0.42) EPHX1CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL25017881 0.83 F10 (0.47) F10F2
SCHEMBL25016727 0.83 F10 (0.47) F10F2
SCHEMBL28588310 0.81 MAPK8 (0.35) F10EPHX1MAPK8DRD2PARP1
SCHEMBL28588309 0.81 MAPK8 (0.35) F10EPHX1MAPK8DRD2PARP1
SCHEMBL30180399 0.81 MAPK8 (0.35) F10EPHX1MAPK8DRD2PARP1
SCHEMBL25016037 0.80 F10 (0.43) F10KMT2AL3MBTL1F2PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 F10 1548/4885EPHX1 3242/4885CACNB4 4456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback